Full Text
Cost-Effectiveness Of Daclizumab Versus Fingolimod In The Treatment Of Patients With Relapsing-Remitting Multiple Sclerosis In Norway

Abstract

Authors

H Toro-Diaz C Cele L Hernandez P Haines Y Liu BM Bjørnstad FS Haukaas

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×